Press Releases

Astellas and Ambrx Initiate Antibody Drug Conjugate Collaboration - Meet the two at next week's BioProcess International Europe Conference - 17-18 April 2013

Apr 08, 2013 10:07 BST Informa Life Sciences Astellas and Ambrx Initiate Collaboration for Discovery and Development of Next-Generation Antibody Drug Conjugates for Oncology

Mar 27, 2013 08:00 GMT Informa Life Sciences Biosimilar Manufacturing - Hot Topic for BioProcess International Europe, 17-18 April 2013, Dusseldorf. 15% discount if you mention this article

Mar 20, 2013 11:25 GMT Magma Ceramics & Catalysts Magma Ceramics & Catalysts was revealed as the fastest growing medium-sized business in the region at this year’s Yorkshire Fastest 50 Awards, which took place at Aspire, Leeds on Friday 15th March 2013.

GE Healthcare Life Sciences - Bridging the Gap Between Upstream and Downstream Bioprocessing

Mar 14, 2013 08:00 GMT Informa Life Sciences BPI Europe's Exclusive interview with Eva Lindskog, GE Healthcare Life Sciences’ Upstream Marketing Segment Leader

Davy Process Technology Ltd and  SEKAB E-Technology AB Form Strategic Partnership

Mar 13, 2013 06:00 GMT SEKAB Davy Process Technology Ltd and SEKAB E-Technology join forces in the development of groundbreaking technology for the production of lignocellulosic sugars, for onward production of ethanol and other green chemicals.

Evolving strategies for successfully developing biosimilars and non-platformed therapeutics

Feb 14, 2013 15:28 GMT Informa Life Sciences Next-generation therapies such as bi-specifics, fusion proteins and fragments offer tremendous benefits on paper, but it’s the bioprocessing departments that have to develop the new production methods, switch to new platforms and investigate new capture steps.

Feb 14, 2013 10:22 GMT

Cell Culture Becomes an Integral Part of Cell Line Development and Engineering

Feb 11, 2013 15:44 GMT Informa Life Sciences Market demands to reduce manufacturing costs require better Cell culture processes

Feb 05, 2013 16:25 GMT Magma Ceramics & Catalysts Magma Ceramics & Catalysts has appointed Martyn Gannon as its new Operations Director.

Deal making in the biosimilars market: increasing investment for decreasing return? - DataMonitor

Feb 05, 2013 08:09 GMT Informa Life Sciences Biosimilars are big business. The global biologics market reached $125 billion in 2011, and is predicted to top $150 billion by the end of 2016. Of this, roughly $60 billion will be in off-patent sales.